"RPLND is an attractive option for those who prefer to avoid chemotherapy," write Jiping Zeng, MD; Timothy A. Masterson, MD; and Clint Cary, MD, MPH, MBA.
Jiping Zeng, MD
Advertisement
Articles by Jiping Zeng, MD
Advertisement
Latest Updated Articles
The role of surgery continues to evolve in seminomaSeptember 24th 2024
Advertisement
Advertisement
Trending on Urology Times
1
Real-world data support PSA below 0.2 ng/mL as key response threshold in mCSPC
2
Higher intake of ultra-processed food associated with increased prostate cancer risk
3
Nima Almassi, MD, highlights long-term data on bladder preservation in MIBC
4
Published LITESPARK-011 data show PFS benefit with belzutifan plus lenvatinib in ccRCC
5